| Tiana Miller-breland, CNM | |
|
4 E Rolling Xrds Ste 110, Catonsville, MD 21228-6277 | |
| (410) 744-9073 | |
| (410) 744-9098 |
| Full Name | Tiana Miller-breland |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 12 Years |
| Location | 4 E Rolling Xrds Ste 110, Catonsville, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376936872 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | R215462 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Seton Medical Group Inc | 7416037924 | 75 |
News Archive
Fred Kummerow, a 94-year-old University of Illinois veterinary biosciences professor emeritus who still conducts research on the health effects of trans fats in the diet, filed the petition with the FDA last month. The petition is now posted on the FDA Web site, and public comments are invited. (See below for information on viewing the petition and making a comment.)
The scars of childhood abuse and neglect affect adults' brains for decades to come - including their ability to process and act on information both quickly and accurately, new research suggests.
Onyx Pharmaceuticals, Inc. today announced that the company has begun enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed multiple myeloma. The company has an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) and received Scientific Advice from the European Medicines Agency (EMA) on the design and planned analysis of the ASPIRE trial.
Violence and conflict in areas affected by war, such as Gaza, can have a devastating effect on the mental health of the children exposed to it, according to research at the University of Leicester.
New research reveals how our brains are able to pick out important sounds from the noisy world around us. The findings, published online today in the journal eLife, could lead to new diagnostic tests for hearing disorders.
› Verified 9 days ago
| Entity Name | University Of Maryland Community Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477530624 PECOS PAC ID: 3678472214 Enrollment ID: O20040102000687 |
News Archive
Fred Kummerow, a 94-year-old University of Illinois veterinary biosciences professor emeritus who still conducts research on the health effects of trans fats in the diet, filed the petition with the FDA last month. The petition is now posted on the FDA Web site, and public comments are invited. (See below for information on viewing the petition and making a comment.)
The scars of childhood abuse and neglect affect adults' brains for decades to come - including their ability to process and act on information both quickly and accurately, new research suggests.
Onyx Pharmaceuticals, Inc. today announced that the company has begun enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed multiple myeloma. The company has an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) and received Scientific Advice from the European Medicines Agency (EMA) on the design and planned analysis of the ASPIRE trial.
Violence and conflict in areas affected by war, such as Gaza, can have a devastating effect on the mental health of the children exposed to it, according to research at the University of Leicester.
New research reveals how our brains are able to pick out important sounds from the noisy world around us. The findings, published online today in the journal eLife, could lead to new diagnostic tests for hearing disorders.
› Verified 9 days ago
| Entity Name | Luminis Health Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073580205 PECOS PAC ID: 2860447315 Enrollment ID: O20050317000146 |
News Archive
Fred Kummerow, a 94-year-old University of Illinois veterinary biosciences professor emeritus who still conducts research on the health effects of trans fats in the diet, filed the petition with the FDA last month. The petition is now posted on the FDA Web site, and public comments are invited. (See below for information on viewing the petition and making a comment.)
The scars of childhood abuse and neglect affect adults' brains for decades to come - including their ability to process and act on information both quickly and accurately, new research suggests.
Onyx Pharmaceuticals, Inc. today announced that the company has begun enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed multiple myeloma. The company has an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) and received Scientific Advice from the European Medicines Agency (EMA) on the design and planned analysis of the ASPIRE trial.
Violence and conflict in areas affected by war, such as Gaza, can have a devastating effect on the mental health of the children exposed to it, according to research at the University of Leicester.
New research reveals how our brains are able to pick out important sounds from the noisy world around us. The findings, published online today in the journal eLife, could lead to new diagnostic tests for hearing disorders.
› Verified 9 days ago
| Entity Name | Seton Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144409194 PECOS PAC ID: 7416037924 Enrollment ID: O20080122000384 |
News Archive
Fred Kummerow, a 94-year-old University of Illinois veterinary biosciences professor emeritus who still conducts research on the health effects of trans fats in the diet, filed the petition with the FDA last month. The petition is now posted on the FDA Web site, and public comments are invited. (See below for information on viewing the petition and making a comment.)
The scars of childhood abuse and neglect affect adults' brains for decades to come - including their ability to process and act on information both quickly and accurately, new research suggests.
Onyx Pharmaceuticals, Inc. today announced that the company has begun enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed multiple myeloma. The company has an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) and received Scientific Advice from the European Medicines Agency (EMA) on the design and planned analysis of the ASPIRE trial.
Violence and conflict in areas affected by war, such as Gaza, can have a devastating effect on the mental health of the children exposed to it, according to research at the University of Leicester.
New research reveals how our brains are able to pick out important sounds from the noisy world around us. The findings, published online today in the journal eLife, could lead to new diagnostic tests for hearing disorders.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tiana Miller-breland, CNM 4 E Rolling Xrds Ste 110, Catonsville, MD 21228-6277 Ph: (410) 744-9073 | Tiana Miller-breland, CNM 4 E Rolling Xrds Ste 110, Catonsville, MD 21228-6277 Ph: (410) 744-9073 |
News Archive
Fred Kummerow, a 94-year-old University of Illinois veterinary biosciences professor emeritus who still conducts research on the health effects of trans fats in the diet, filed the petition with the FDA last month. The petition is now posted on the FDA Web site, and public comments are invited. (See below for information on viewing the petition and making a comment.)
The scars of childhood abuse and neglect affect adults' brains for decades to come - including their ability to process and act on information both quickly and accurately, new research suggests.
Onyx Pharmaceuticals, Inc. today announced that the company has begun enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed multiple myeloma. The company has an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) and received Scientific Advice from the European Medicines Agency (EMA) on the design and planned analysis of the ASPIRE trial.
Violence and conflict in areas affected by war, such as Gaza, can have a devastating effect on the mental health of the children exposed to it, according to research at the University of Leicester.
New research reveals how our brains are able to pick out important sounds from the noisy world around us. The findings, published online today in the journal eLife, could lead to new diagnostic tests for hearing disorders.
› Verified 9 days ago